Artículos por temáticas

Kinesiology training in patients with Parkinson's disease: results of a pilot study

Kuhn W, Neufeld T, Müller T.

J Neural Transm (Vienna). 2020 May;127(5):793-798. doi: 10.1007/s00702-019-02123-8. Epub 2020 Jan 9.

The Cumulative Effect of Transient Synchrony States on Motor Performance in Parkinson's Disease

Tinkhauser G, Torrecillos F, Pogosyan A, Mostofi A, Bange M, Fischer P, Tan H, Hasegawa H, Glaser M, Muthuraman M, Groppa S, Ashkan K, Pereira EA, Brown P.

J Neurosci. 2020 Feb 12;40(7):1571-1580. doi: 10.1523/JNEUROSCI.1975-19.2019. Epub 2020 Jan 9.

Nine-years follow-up of cavernoma located in basal ganglia mimicking Parkinson's disease

Modreanu RM, Buhmann C, Hauptmann B.

Clin Neurol Neurosurg. 2020 Mar;190:105664. doi: 10.1016/j.clineuro.2020.105664. Epub 2020 Jan 2.

Machine learning methods for optimal prediction of motor outcome in Parkinson's disease

Salmanpour MR, Shamsaei M, Saberi A, Klyuzhin IS, Tang J, Sossi V, Rahmim A.

Phys Med. 2020 Jan;69:233-240. doi: 10.1016/j.ejmp.2019.12.022. Epub 2020 Jan 7.

Brain structural correlates of depressive symptoms in Parkinson's disease patients at different disease stage

Li Y, Huang P, Guo T, Guan X, Gao T, Sheng W, Zhou C, Wu J, Song Z, Xuan M, Gu Q, Xu X, Yang Y, Zhang M.

Psychiatry Res Neuroimaging. 2020 Feb 29;296:111029. doi: 10.1016/j.pscychresns.2019.111029. Epub 2019 Dec 28.

Characteristics of oscillatory pallidal neurons in patients with Parkinson's disease

Meng D, Zhuang P, Hallett M, Zhang Y, Li J, Hu Y, Li Y.

J Neurol Sci. 2020 Mar 15;410:116661. doi: 10.1016/j.jns.2019.116661. Epub 2019 Dec 30.

The protective effect of inosine against rotenone-induced Parkinson's disease in mice; role of oxido-nitrosative stress, ERK phosphorylation, and A2AR expression

El-Shamarka MEA, Kozman MR, Messiha BAS.

Naunyn Schmiedebergs Arch Pharmacol. 2020 Jun;393(6):1041-1053. doi: 10.1007/s00210-019-01804-1. Epub 2020 Jan 8.

Transient parkinsonism associated with acute Legionnaires' disease

Su JS, Honsberger S, Husnain MG.

BMJ Case Rep. 2020 Jan 7;13(1):e233152. doi: 10.1136/bcr-2019-233152.

Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson's disease

Fan Z, Pan YT, Zhang ZY, Yang H, Yu SY, Zheng Y, Ma JH, Wang XM.

J Neuroinflammation. 2020 Jan 8;17(1):11. doi: 10.1186/s12974-019-1670-6.

Decreased Penetrance of Parkinson's Disease in Elderly Carriers of Glucocerebrosidase Gene L444P/R Mutations: A Community-Based 10-Year Longitudinal Study

Ji S, Wang C, Qiao H, Gu Z, Gan-Or Z, Fon EA, Chan P.

Mov Disord. 2020 Apr;35(4):672-678. doi: 10.1002/mds.27971. Epub 2020 Jan 8.

Melatonin/polydopamine nanostructures for collective neuroprotection-based Parkinson's disease therapy

Srivastava AK , Roy Choudhury S , Karmakar S .

Biomater Sci. 2020 Mar 7;8(5):1345-1363. doi: 10.1039/c9bm01602c. Epub 2020 Jan 8.

Baicalin attenuated substantia nigra neuronal apoptosis in Parkinson's disease rats via the mTOR/AKT/GSK-3β pathway.

Zhai H, Kang Z, Zhang H, Ma J, Chen G.

J Integr Neurosci. 2019 Dec 30;18(4):423-429. doi: 10.31083/j.jin.2019.04.192.

Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis

Devos D, Cabantchik ZI, Moreau C, Danel V, Mahoney-Sanchez L, Bouchaoui H, Gouel F, Rolland AS, Duce JA, Devedjian JC; FAIRPARK-II and FAIRALS-II studygroups.

J Neural Transm (Vienna). 2020 Feb;127(2):189-203. doi: 10.1007/s00702-019-02138-1. Epub 2020 Jan 7.

Replacing what's lost: a new era of stem cell therapy for Parkinson's disease

Fan Y, Winanto, Ng SY.

Transl Neurodegener. 2020 Jan 7;9:2. doi: 10.1186/s40035-019-0180-x. eCollection 2020.

The drug adaptaquin blocks ATF4/CHOP-dependent pro-death Trib3 induction and protects in cellular and mouse models of Parkinson's disease

Aimé P, Karuppagounder SS, Rao A, Chen Y, Burke RE, Ratan RR, Greene LA.

Neurobiol Dis. 2020 Mar;136:104725. doi: 10.1016/j.nbd.2019.104725. Epub 2020 Jan 3.